Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or South Dakota for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to South Dakota only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. South Dakota (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jennifer May (NPI 1891765475)

Field	Value
Entity Type	Individual
Organization	Jennifer May
Address	3024 Tower Rd Ste 2
City	Rapid City
State	SD
ZIP	57701
Taxonomy	Internal Medicine Physician
NPI Enumerated	January 25, 2006

Payer Source	Total Paid
Medicare	$1.9M
Medicaid	$0

Key Findings

This provider’s billed Medicare revenue totals $1.9M while there is no Medicaid billing on file, meaning the practice is effectively single‑payer in the dataset and financially concentrated in Medicare receipts rather than a mixed Medicare/Medicaid payer mix. Absence of any Medicaid claims limits conclusions about in‑state Medicaid market share or contract participation.

Revenue is highly concentrated in a small set of biologic injection codes: the precomputed top three codes (J3380, J3262, J9312) account for 54.5% of this provider’s total Medicare revenue, with J3380 reported at $494.7K (26.1%), J3262 at $289.2K (15.2%), and J9312 at $249.6K (13.2%). This concentration indicates the practice derives the majority of its Medicare dollars from a few high‑cost injectable biologics rather than from routine evaluation & management visits.

The CPT/HCPCS mix indicates an infusion‑centric operation focused on IV and parenteral biologic therapies: high‑revenue drugs listed include vedolizumab (J3380), tocilizumab (J3262), rituximab (J9312), golimumab (J1602), and infliximab (J1745). Supportive infusion and chemotherapy administration codes are present (e.g., 96365 with 425 claims and $19.6K revenue, 96413 with 160 claims and $14.9K revenue, and 96415 with 241 claims and $5.1K revenue), signposting an on‑site infusion suite or regular IV administration services rather than a visit‑driven primary care model.

Clinical visit codes generate comparatively modest revenue versus drug administration: 99214 appears with 499 claims and $41.4K (2.2% of Medicare revenue) and 99213 with 43 claims and $2.1K (0.1%). This suggests the practice’s economics are dominated by drug/infusion reimbursement rather than face‑to‑face E/M throughput.

For vedolizumab (J3380) the provider ranks #30 of 620 nationally and is described as notably above typical national volume (95th percentile), identifying this clinician as a high‑volume national outlier for that specific biologic. That ranking supports the view that the provider is a regional or specialty focal point for vedolizumab administration relative to peers.

Other high‑cost biologics show more typical participation: J3262 (tocilizumab) ranks #190 of 618 (69th percentile) and J9312 (rituximab) ranks #118 of 317 (61th percentile), both described as typical or unremarkable volume. These placements indicate the provider is a modest/typical national participant for several biologics even as J3380 is a standout.

Several infusion/administration procedure codes sit at high national percentiles (96365 at the 94th percentile, 96372 at the 94th percentile, and 96415 at the 92th percentile), reinforcing that the practice maintains significant infusion throughput and capacity. Taken together with the drug revenue mix, these administration‑code percentiles point to an operational emphasis on delivering IV biologic therapies on site.

The provider’s NPI was enumerated on 2006-01-25 (~20 years ago), indicating long tenure in the Medicare program; this longevity, combined with concentrated biologic billing, suggests an established practice with a stable focus on infusion‑delivered specialty therapies. The lack of Medicaid billing on file could reflect nonparticipation in Medicaid, a patient panel skewed toward Medicare ages, or billing/capture differences, and it limits evaluation of the provider’s role in Medicaid networks.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

42 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3380	Injection, vedolizumab, intravenous, 1 mg	29,100	$20	$494.7K
J3262	Injection, tocilizumab, 1 mg	57,840	$10	$289.2K
J9312	Injection, rituximab, 10 mg	3,900	$60	$249.6K
J1602	Injection, golimumab, 1 mg, for intravenous use	20,770	$10	$207.7K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	6,370	$30	$165.6K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	33,600	$1	$134.4K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	3,150	$30	$107.1K
J0897	Injection, denosumab, 1 mg	5,520	$20	$99.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	500	$80	$41.4K
J1439	Injection, ferric carboxymaltose, 1 mg	33,000	$1	$33K

Showing 1–10 of 42

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 42 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. South Dakota Distribution

Jennifer May — 12 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — South Dakota

Full comparison — all codes billed, vs. state median

42 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3380	1	10	24,000	$20	$412.6K
J3262	1	10	51,240	$1	$228.4K
J1602	1	10	18,780	$10	$189.1K
J0717	2	10	33,600	$1	$175.6K
J9312	1	10	1,850	$60	$158.7K
J0129	2	10	3,610	$30	$120.4K
J1745	1	10	4,300	$30	$97.2K
J0897	5	40	2,460	$20	$52.8K
J1439	1	10	26,630	$1	$23K
96413	5	10	110	$100	$13.5K

Showing 1–10 of 42

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jennifer May, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Monument Health Rapid City Hospital, Inc	SD	Multi-Specialty Clinic/Center	$0	$18.7M
Monument Health Rapid City Hospital, Inc.	SD	General Acute Care Hospital	$0	$11.5M
Monument Health Rapid City Hospital, Inc.	SD	Multi-Specialty Clinic/Center	$0	$5.2M
Rapid City Medical Center, LLP	SD	Multi-Specialty Clinic/Center	$0	$4.5M
Richard White	AR	Hematology & Oncology Physician	$2.2M	$0
Monument Health Network, Inc.	SD	Multi-Specialty Clinic/Center	$0	$2M
Monument Health Network, Inc.	SD	Multi-Specialty Clinic/Center	$0	$1.8M
Monument Health Rapid City Hospital, Inc.	SD	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$1.6M
Luke Hushagen	SD	Internal Medicine Physician	$1.4M	$0
Don Wynn	TX	Pulmonary Disease Physician	$1.4M	$0

Nearby Providers

Other providers in the same ZIP code as Jennifer May, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Behavior Management Systems, Inc.	SD	Community/Behavioral Health Agency	$0	$19.8M
Community Health Center Of The Black Hills Inc	SD	Federally Qualified Health Center (FQHC)	$0	$10.2M
Jrk Services, Inc	SD	Home Health Agency	$0	$10.1M
Black Hills Pediatrics, LLP	SD	Pediatrics Physician	$0	$9.7M
Rapid City Emergency Services PA	SD	Emergency Medicine Physician	$0	$8.2M
Wellspring Inc.	SD	Psychiatry Physician	$0	$7.4M
Prema Abraham	SD	Retina Specialist (Ophthalmology) Physician	$7.1M	$0
Radiology Associates Prof, LLC	SD	Diagnostic Radiology Physician	$0	$5.3M
City Of Rapid City	SD	Ambulance	$1.4M	$3.7M
Black Hills Oral & Maxillofacial Surgery PC	SD	Oral and Maxillofacial Pathology Dentistry	$0	$3.2M

Jennifer May — Billing Profile & Reimbursement Data

Sign up for Jennifer May — Billing Profile & Reimbursement Data policy alerts

Jennifer May — Billing Profile & Reimbursement Data

Sign up for Jennifer May — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References